CLINICAL STUDY AGREEMENT PROTOCOL: 2125-MEL-301 SITE: 301prof. Petr Arenberger, M.D., DrSc., MBA IDERA PHARMACEUTICALS, INC. 20-JUN-2018 VERSION: VERSION#1COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉ STUDII PROTOKOL: 2125-MEL-301 PRACOVIŠTĚ: 301prof....

External Document